SCHEMBL9306818

SCHEMBL9306818

CN1CCC2=C(CCc3ccccc32)C1

nearest known ligand 0.76

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 7/20 0.64
CHRM2 P08172 1/20 0.63
HTR1A P08908 1/20 0.63
ADRA2A P08913 1/20 0.63
CHRM1 P11229 1/20 0.63
DRD1 P21728 1/20 0.63
SLC6A2 P23975 1/20 0.63
SLC6A4 P31645 1/20 0.63
ADRA1A P35348 1/20 0.63
OPRM1 P35372 1/20 0.63
DRD3 P35462 1/20 0.63
SLC6A3 Q01959 1/20 0.63
KCNH2 Q12809 1/20 0.63
SETD7 Q8WTS6 1/20 0.59
MAOA P21397 2/20 0.53
MAOB P27338 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9308470 0.98 SIGMAR1 (0.67) SIGMAR1CHRM2HTR1AADRA2ACHRM1
SCHEMBL13663060 0.86 DRD1 (0.73) SIGMAR1CHRM2HTR1AADRA2ACHRM1
SCHEMBL9309721 0.80 SIGMAR1 (0.97) SIGMAR1CHRM2HTR1AADRA2ACHRM1
SCHEMBL9309563 0.77 SIGMAR1 (0.97) SIGMAR1
Setiptiline SCHEMBL211362 0.77 DRD1 (1.00) SIGMAR1CHRM2HTR1AADRA2ACHRM1
Setiptiline SCHEMBL29414110 0.77 DRD1 (1.00) SIGMAR1CHRM2HTR1AADRA2ACHRM1
SCHEMBL9308002 0.77 SIGMAR1 (0.55) SIGMAR1CHRM2HTR1AADRA2ACHRM1
Hydrochloric Acid SCHEMBL9308175 0.76 SIGMAR1 (1.00) SIGMAR1
SCHEMBL12355565 0.76 DRD1 (0.73) SIGMAR1CHRM2HTR1AADRA2ACHRM1
SCHEMBL10728179 0.76 DRD1 (0.86) SIGMAR1CHRM2HTR1AADRA2ACHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5294618-A Psychological disorders MERCK SHARP & DOHME LIMITED (GB) 1994-03-15 US disclosed
EP-0410535-A2 Octahydrobenzisoquinoline derivatives as antipsychotic agents MERCK SHARP & DOHME LTD. (GB) 1991-01-30 EP disclosed
EP-0106487-A2 Improvements in or relating to novel bridged hexahydrobenz(f)isoquinolines ELI LILLY AND COMPANY (US) 1984-04-25 EP disclosed
US-4166183-A TRICYCLIC CYCLITOLAMINES E. R. SQUIBB & SONS, INC. (US) 1979-08-28 US disclosed